Exodus Point Capital Management, LP Acadia Pharmaceuticals Inc Transaction History

Exodus Point Capital Management, LP

$14.6 Billion
Q4 2024

A detailed history of Exodus Point Capital Management, LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 70,786 shares of ACAD stock, worth $1.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

70,786

Previous 58,901 20.18%

Holding current value

$1.22 Million

Previous $906,000 43.38%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$14.29 - $18.76 $169,836 - $222,962	11,885 Added 20.18%	70,786 $1.3 Million
Q3 2024 Nov 12, 2024	BUY	$15.14 - $19.14 $163,754 - $207,018	10,816 Added 22.49%	58,901 $906,000
Q2 2024 Aug 13, 2024	SELL	$14.62 - $18.42 $1.04 Million - $1.32 Million	-71,407 Reduced 59.76%	48,085 $781,000
Q1 2024 May 14, 2024	SELL	$17.79 - $30.86 $2.8 Million - $4.86 Million	-157,337 Reduced 56.84%	119,492 $2.21 Million
Q3 2023 Nov 09, 2023	BUY	$20.84 - $33.47 $5.77 Million - $9.27 Million	276,829 New	276,829 $5.77 Million
Q1 2023 May 11, 2023	SELL	$16.32 - $20.92 $6 Million - $7.7 Million	-367,953 Reduced 78.82%	98,890 $1.86 Million
Q4 2022 Feb 13, 2023	BUY	$14.2 - $18.63 $5.76 Million - $7.56 Million	405,846 Added 665.35%	466,843 $7.43 Million
Q3 2022 Nov 10, 2022	BUY	$14.11 - $18.27 $228,920 - $296,412	16,224 Added 36.24%	60,997 $998,000
Q2 2022 Aug 19, 2022	SELL	$13.01 - $27.22 $377,133 - $789,053	-28,988 Reduced 39.3%	44,773 $631,000
Q1 2022 May 13, 2022	BUY	$20.94 - $27.5 $1.54 Million - $2.03 Million	73,761 New	73,761 $1.79 Million
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $476,366 - $747,756	-30,188 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $82,042 - $115,959	4,229 Added 16.29%	30,188 $736,000
Q1 2021 May 17, 2021	SELL	$25.02 - $54.99 $740,516 - $1.63 Million	-29,597 Reduced 53.27%	25,959 $670,000
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $1.68 Million - $2.32 Million	40,844 Added 277.62%	55,556 $2.97 Million
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $4.6 Million - $7.2 Million	-126,294 Reduced 89.57%	14,712 $607,000
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $5.21 Million - $7 Million	132,778 Added 1613.73%	141,006 $6.84 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $1.22 Million - $1.81 Million	-38,553 Reduced 82.41%	8,228 $348,000
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $1.69 Million - $2.4 Million	46,781 New	46,781 $2 Million

Others Institutions Holding ACAD

# of Institutions

315

Shares Held

164M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.79B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Acadia Pharmaceuticals Inc Transaction History